AMO Receives FDA Approval for New Intraocular Lens

The Food and Drug Administration (FDA) has just approved a new intraocular lens (IOL) created by Advanced Medical Optics, Inc. (AMO). AMO's TECNIS Multifocal IOL will be used with cataract patients.

The TECNIS Multifocal IOL provides cataract patients with better near vision and reading speed than other IOLs on the market. The TECNIS Multifocal IOL also gives patients very high spectacle independence. Approximately 90% of patients receiving this lens do not need glasses after their surgery.

The TECNIS Multifocal IOL also offers patients the following additional benefits:

• Excellent near, intermediate, and far vision during the day and at night
  
• The first ever pupil-independent, non-apodized, fully diffractive aspheric lens created to treat the two highest order aberrations -- spherical and chromatic -- returning patients' vision to levels they experienced when they were young
  
• A higher satisfaction rate than any presbyopia-correcting IOL on the market
  

AMO plans on making the TECNIS Multifocal IOL available to ophthalmologists in early 2009.